Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Submit your nominations for the Fierce CRO Awards
lipid nanoparticle drug delivery tech
Biotech
Tune Tx's $175M series B to fund epigenetic HBV therapy's trials
Investors clearly appreciate the song that Tune Therapeutics is singing, handing over $175 million in series B funds.
James Waldron
Jan 13, 2025 8:23am
Etherna lands $950M biobucks deal with Kenneth Chien's Dropshot
Jan 9, 2025 1:05pm
Vertex and Orna team up to develop new blood disorder treatments
Jan 7, 2025 7:00am
Oncology biotech licenses Genevant tech for up to $123M
Dec 20, 2024 6:00am
2 biotechs shed staff, fuse to form genetic medicine company
Dec 11, 2024 7:00am
mRNA therapy reduced post-surgery eye scarring in rabbits
Nov 27, 2024 2:00pm